Trademarkia Logo

Canada

C$
MINT PHARMACEUTICALS
REGISTERED

on 18 Oct 2021

Last Applicant/ Owned by

MINT PHARMACEUTICALS INC.

1093 Meyerside DriveUnit 1Mississauga

ONTARIO

CA

L5T1J6

Serial Number

1890783 filed on 28th Mar 2018

Registration Number

TMA1111791 registered on 18th Oct 2021

Registration expiry Date

18th Oct 2031

Correspondent Address

BLANEY MCMURTRY LLP

Suite 15002 Queen Street EastToronto

ONTARIO

CA

M5C3G5

MINT PHARMACEUTICALS

Trademark usage description

chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pha Read More

Classification Information


Class [001]
Chemicals for use as intermediates in the manufacture of pharmaceutically active compounds and for use as active ingredients in the manufacture of pharmaceutical preparations


Classification kind code

11

Class [005]
Pharmaceutical preparations, namely, acne medications, fertility enhancement preparations for human use, antibiotics, anti-viral agents, pharmaceutical preparations for the treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes, pharmaceutical preparations for the treatment of smoking cessation, antihistamines, cough treatment medications, pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, bulimia, nervosa, anorexia, obesity and hypothyroidism, antiarrhythmic drugs, antipyretic drugs with sedative effect, antituberculous drugs, antitumor drugs, pharmaceutical preparations for suppressing tumours, inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders, pharmaceutical cold preparations, pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension, pharmaceutical preparations for regulating the immune system, pharmaceutical preparations for the treatment of blood disorders, pharmaceutical preparations for the treatment of gout; medicinal marijuana for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bi-polar disorder, depression, and insomnia; medicinal cannabis for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bi-polar disorder, depression, and insomnia; tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV) and cannabinoids; medicinal marijuana in the form of pills, tablets, capsules, transdermal patches, topical creams, gels, nasal sprays, suppositories, sublingual doses, mucus membrane doses, film; strips, liquids, powders, all for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bi-polar disorder, depression, and insomnia; medicinal cannabis in the form of pills, tablets, capsules, transdermal patches, topical creams, gels, nasal sprays, suppositories, sublingual doses, mucus membrane doses, film strips, liquids, powders, all for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bipolar disorder, depression, and insomnia; pharmaceutical preparations containing tetrahydrocannabinol (THC), pharmaceutical preparations containing cannabidiol (CBD), pharmaceutical preparations containing tetrahydrocannabivarin (THV), pharmaceutical preparations containing cannabinoids, all for use in the treatment of nausea, vomiting, pain, loss of appetite, muscle tension, muscle spasms, epilepsy, glaucoma, multiple sclerosis, arthritis, Parkinson's disease, cancer, gastrointestinal illness, spinal cord injury, anxiety, bipolar disorder, depression, and insomnia; dietary and nutritional supplements containing cannabis extracts, dietary and nutritional supplements containing cannabis oil, dietary and nutritional supplements containing tetrahydrocannabinol (THC), dietary and nutritional supplements containing cannabidiol (CBD), dietary and nutritional supplements containing tetrahydrocannabivarin (THV), dietary and nutritional supplements containing cannabinoids


Classification kind code

11

Class [010]
Inhalers for therapeutic use, aerosol dispensers for medical purposes


Classification kind code

11

Class [016]
Pharmaceutical information leaflets


Classification kind code

11

Class [029]
Meats and processed foods


Comment text

CIPO Classification Code

Classification kind code

Nice

Class [030]
Food products containing cannabis, namely chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing hashish, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing cannabis resins, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars, food products containing cannabis oil, namely, chocolates, cookies, brownies, pastries, cakes, candy and food energy bars


Classification kind code

11

Class [031]
Live cannabis plants, seeds for growing cannabis plants


Classification kind code

11

Class [032]
Fruit juices, smoothies, carbonated soft drinks and energy drinks, all containing cannabis, fruit juices, smoothies, carbonated soft drinks and energy drinks, all containing hashish, fruit juices, smoothies, carbonated soft drinks and energy drinks, all containing cannabis resins, fruit juices, smoothies, carbonated soft drinks and energy drinks, all containing cannabis oil


Classification kind code

11

Class [033]
Alcoholic energy drinks


Classification kind code

11

Class [034]
Dried cannabis; dried marijuana; cannabis extracts, namely, hashish, resins, cannabidiol [CBD] and tetrahydrocannabinol [THC] oil for electronic cigarettes; cannabis extracts, namely, hashish, resins, cannabidiol [CBD] and tetrahydrocannabinol [THC] oil for vaporizers for smoking


Classification kind code

11

Class [035]
Sales of medical devices of others


Classification kind code

11

Class [040]
Assembly of pharmaceuticals for others


Classification kind code

11

Class [042]
Development of pharmaceutical preparations and medicines; pharmaceutical research and development


Classification kind code

11

Class [044]
Advisory and consultancy services in the use of medicinal marijuana, medicinal cannabis, tetrahydrocannabinol (THC), cannabidiol (CBD), tetrahydrocannabivarin (THV) and cannabinoids


Classification kind code

11

Mark Details


Serial Number

1890783

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 26
on 24th May 2021
Approved
Submitted for opposition 15
on 25th Mar 2021
Correspondence Created
Submitted for opposition 15
on 12th May 2020
Correspondence Created
Submitted for opposition 22
on 29th Aug 2019
Search Recorded
Submitted for opposition 20
on 29th Aug 2019
Examiner's First Report
Submitted for opposition 87
on 26th Jun 2018
Rep for Service Changed
Submitted for opposition 48
on 26th Jun 2018
Agent Changed
Submitted for opposition 31
on 5th Apr 2018
Formalized
Submitted for opposition 1
on 29th Mar 2018
Created
Submitted for opposition 30
on 28th Mar 2018
Filed